Bing Han

机构：Qingdao University, Soochow University, Fifth Tianjin Central Hospital, Affiliated Hospital of Qingdao University, First Hospital of China Medical University, First Affiliated Hospital of Soochow University, Qilu Hospital of Shandong University, China Medical University · ORCID：0000-0003-3447-0513

发表论文 57 篇 · 总被引 1010 次 · h-index 17

代表论文

• Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis (2022 · Frontiers in Immunology · 被引 21)
• Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer (2022 · International Journal of Molecular Sciences · 被引 16)
• SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer (2022 · Aging · 被引 14)
• Monitoring HOTTIP levels on extracellular vesicles for predicting recurrence in surgical non-small cell lung cancer patients (2021 · Translational Oncology · 被引 13)
• Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines (2022 · Journal of Experimental & Clinical Cancer Research · 被引 6)
• Extracellular matrix remodeling fibroblasts govern the tumor microenvironment disparity between adenomatous lesions and adenocarcinoma in gallbladder (2025 · Frontiers in Immunology · 被引 5)